Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $192.11M | $167.79M | $160.35M | $51.57M |
| Net Income | $320.08M | -$2.92M | $25.87M | -$71.43M |
| EPS Diluted | $2.21 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.03 |
| $0.21 |
| -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.